✨ Ask AkshayaAI anything about this stock — instant AI answers. Try the AI assistant →
AkshayaAIStocks › DXCM

DXCM — Dexcom Inc

AI Signal & Stock Analysis · Very Strong ↑

As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for DXCM is Very Strong ↑; the stock is at $89.87 (-1.76% today); neutral (RSI 68); technical trend is Raise; news sentiment is nan.

Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.

Key metrics

AI signal (Strength)Very Strong ↑
Price$89.87
Change today-1.76%
RSI (14)67.83
Relative volume0.42
Composite (RMTPGV) score🔒 members
Market cap$33.9B
Forward P/E28.80
52-week high-1.9% away
52-week low+66.2% above
Technical trendRAISE-2024-01-26
News sentimentNan
SectorHealthcare-Devices
Next earnings7/30/2026 4:30:00 PM

What's driving the signal

🔒 AkshayaAI factor scores — Momentum, Technical, Performance, Growth, Volatility and the composite RMTPGV score are members-only. Sign in free to see the full breakdown →
Ask a follow-up or get live data on DXCM → open the AI assistant

Frequently asked about DXCM

What is AkshayaAI's signal for DXCM today?

As of Aug 14 2026, 1:04 PM, AkshayaAI assigns DXCM (Dexcom Inc) a Very Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.

Is DXCM overbought or oversold right now?

DXCM's RSI is neutral (RSI 68). A reading above 70 is typically considered overbought and below 30 oversold.

Where is DXCM in its 52-week range?

DXCM is trading about 2% below its 52-week high and 66% above its 52-week low as of Aug 14 2026, 1:04 PM.

When is DXCM's next earnings date?

DXCM's next earnings date is 7/30/2026 4:30:00 PM.

What sector is DXCM in?

DXCM is classified under Healthcare-Devices in AkshayaAI's taxonomy.

AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.

🤖

Ask AkshayaAI about DXCM

Instant, data-backed answers — free to try.